Table 2 Correlation between non-sentinel lymph node metastasis and clinicopathological features
Variables | No metastasis (n = 154) | Metastasis (n = 126) | P-value |
|---|---|---|---|
Age | Â | Â | 0.524 |
  ≤ 50 | 76 (49.35%) | 67 (53.17%) |  |
  > 50 | 78 (50.65%) | 59 (46.83%) |  |
BMI | Â | Â | 0.378 |
   ≤ 25 | 105 (68.18%) | 92 (73.02%) |  |
   > 25 | 49 (31.82%) | 34 (26.98%) |  |
Tumor size (cm) | Â | Â | 0.012 * |
   ≤ 2 | 61 (39.61%) | 32 (25.40%) |  |
   > 2 | 93 (60.39%) | 94 (74.60%) |  |
Histological stage | Â | Â | 0.580 |
 Midddle/low | 124 (80.52%) | 107 (84.92%) |  |
 High | 16 (10.39%) | 9 (7.14%) |  |
 Unknown | 14 (9.09%) | 10 (7.94%) |  |
Ki-67 | Â | Â | 0.243 |
 Negative | 115 (74.67%) | 88 (69.84%) |  |
 Positive | 37 (24.03%) | 38 (30.16%) |  |
 Unknown | 2 (1.30%) | 0 (0.00%) |  |
HER2 | Â | Â | 0.044 * |
 Negative | 127 (82.47%) | 88 (69.84%) |  |
 Positive | 26 (16.88%) | 37 (29.37%) |  |
 Unknown | 1 (0.65%) | 1 (0.79%) |  |
ER | Â | Â | 0.962 |
 Negative | 26 (16.88%) | 21 (16.67%) |  |
 Positive | 128 (83.12%) | 105 (83.33%) |  |
PR | Â | Â | 0.861 |
 Negative | 43 (27.92%) | 34 (26.98%) |  |
 Positive | 111 (72.08%) | 92 (73.02%) |  |
LVI |  |  |  < 0.001 * |
 Negative | 104 (67.53%) | 32 (25.40%) |  |
 Positive | 50 (32.47%) | 94 (74.60%) |  |
Number SLNM |  |  |  < 0.001 * |
 1 | 110 (71.43%) | 45 (35.71%) |  |
  > 1 | 44 (28.57%) | 81 (64.29%) |  |
Menopause | Â | Â | 0.874 |
 No | 89 (57.79%) | 74 (58.73%) |  |
 Yes | 65 (42.21%) | 52 (41.27%) |  |